XML 52 R2.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 125,200 $ 69,856
Accounts receivable, net 47,818 97,572
Inventory 36,192 22,567
Investment in marketable securities 59,224 344
Other current assets 10,383 3,479
Total current assets 278,817 193,818
Property and equipment, net 18,404 58,388
Intangible assets 15,000 16,260
Total assets 312,221 268,466
Current liabilities:    
Accounts payable 203,126 246,551
Accrued expenses 441,082 438,552
Accrued expenses, related parties 680,119 332,174
Deferred revenues 70,072 26,000
Convertible promissory note, net of discount, past due 1,099,278 1,293,109
Convertible notes, related parties 884,546 884,546
Notes payable 308,000 265,000
Derivative liabilities 223,536 232,162
Total current liabilities 3,909,759 3,718,094
Commitments and contingencies
Stockholders' deficit:    
Common stock, $0.0001 par value; 2,071,000,000 shares authorized; 71,419,795 and 63,363,436 shares issued and outstanding at December 31, 2019 and 2018, respectively 7,142 6,336
Additional paid-in capital 19,954,738 19,367,130
Accumulated deficit (23,559,519) (22,823,194)
Total stockholders' deficit (3,597,538) (3,449,628)
Total liabilities and stockholders' deficit 312,221 268,466
Series A Preferred Stock [Member]    
Stockholders' deficit:    
Preferred Stock Value 100 100
Total stockholders' deficit 100 100
Series B Preferred Stock [Member]    
Stockholders' deficit:    
Preferred Stock Value 1
Total stockholders' deficit $ 1